Animal Parasitic Diseases Laboratory, Agricultural Research Service, USDA, Beltsville, MD 20705, USA; Shangdong Binzhou Academy of Animal Science and Veterinary Medicine, Binzhou City, Shandong 256600, China.
Exp Parasitol. 2013 Oct;135(2):246-56. doi: 10.1016/j.exppara.2013.07.001. Epub 2013 Jul 11.
The present study is the first characterization of Neospora caninum macrophage migration inhibitory factor (NcMIF). BLAST-N analysis of NcMIF revealed high similarity (87%) to the Toxoplasma gondii MIF. NcMIF was cloned and expressed in Escherichia coli in 3 forms, NcMIF (mature protein), NcMIFm (mutation of proline-2 to glycine), and NcMIFhis (addition of a polyhistidine tag at the N-terminus). None of these recombinant NcMIFs (rNcMIF) had tautomerase, oxidoreductase, or immunologic regulatory activities. rNcMIF was unable to compete with recombinant human MIF for a MIF receptor (CD74), suggesting that NcMIF does not bind to this MIF receptor. The glycine substitution for proline-2 of NcMIF resulted in increased retention time on SEC-HPLC and decreased formation of dimers and trimers. The addition of N-terminal HIS-tag led to increased formation of trimers. Immunofluorescence staining demonstrated that NcMIF was localized to the apical end of N. caninum tachyzoites. Immunoelectron microscopy further revealed that NcMIF was present in the micronemes, rhoptries, dense granules, and nuclei. NcMIF was abundant in the tachyzoite lysate and present in excretory and secretory antigen (ESAg) preparations. Total and secretory NcMIF was more abundant in a non-pathologic clone, Ncts-8, than in the wild type isolate (NC1). Furthermore, NcMIF release by the both isolates was increased in the presence of calcium ionophore. This differential production of NcMIF by the pathologic and non-pathologic isolates of N. caninum may suggest a critical role of this molecule in the infectious pathogenesis of this parasite.
本研究首次对刚地弓形虫巨噬细胞移动抑制因子(Toxoplasma gondii MIF)进行了特征描述。BLAST-N 分析表明,NcMIF 与 T. gondii MIF 具有高度相似性(87%)。NcMIF 在大肠杆菌中以 3 种形式进行克隆和表达,分别为 NcMIF(成熟蛋白)、NcMIFm(脯氨酸 2 突变为甘氨酸)和 NcMIFhis(N 端添加多组氨酸标签)。这些重组 NcMIF(rNcMIF)均不具有 tautomerase、oxidoreductase 或免疫调节活性。rNcMIF 不能与重组人 MIF 竞争 MIF 受体(CD74),表明 NcMIF 不与该 MIF 受体结合。NcMIF 中脯氨酸 2 突变为甘氨酸导致 SEC-HPLC 保留时间延长,二聚体和三聚体形成减少。N 端 HIS 标签的添加导致三聚体形成增加。免疫荧光染色表明 NcMIF 定位于刚地弓形虫速殖子的顶端。免疫电镜进一步显示,NcMIF 存在于微线体、棒状体、致密颗粒和核内。NcMIF 在速殖子裂解物中含量丰富,存在于排泄分泌抗原(ESAg)制剂中。在非病理克隆 Ncts-8 中,总 NcMIF 和分泌性 NcMIF 的含量均高于野生型分离株(NC1)。此外,两种分离株的 NcMIF 释放量在钙离子载体存在时增加。刚地弓形虫病理和非病理分离株对 NcMIF 的不同产生可能表明该分子在寄生虫感染发病机制中具有关键作用。